Skin of Color
Neal Bhatia, MD, Chief Medical Editor
Going generic may not be a panacea after all.
Mark D. Kaufmann, MD
How to identify and develop successor for this vital leadership role.
Some vital trends may develop in 2018 to impact your dermatology marketing strategy.
Yoseph Dalia, BS and Sandra Marchese Johnson, MD
A look at where these modalities fit into the treatment approach in 2018.
Michael H. Gold, MD
Will SC infringe on the rights of non-certified dermatologists to preform Mohs? Could it lead to reduced exposure to this and other surgical treatments for future dermatologists in training?
Andrew Weinstein, MD, FAAD
A look at the proposed new classification system, grouping the histiocytoses into five categories, with tabular summaries for differential diagnosis.
Jolie Krooks, BS, Milen Minkov, MD, PhD, and Klemens Rappersberger, MD
Experts weigh in on the current state of SPF and skin protection.
Winning the war on non-melanoma skin cancer.
Steps to take to insure the value of your future income.
Jason M. O'Dell, MS, CWM
Here's a look at the diagnosis of an “eczematous” condition with an unclear etiology.
Alison D. Treister, BS, BSHS and Peter A. Lio, MD
Top cosmeceutical picks from Cosmetic Surgery Forum! From melasma therapy to sunscreen, the founder of CSF shares his favorite cosmeceuticals.
Joel Schlessinger, MD
New recommendations from the United States Preventive Services Task Force seem to limit the PCP's role in patient UV education.
Jonathan Wolfe, MD
New products and pharmacologic developments
Stay up to date on all things Dermatology by signing up to recieve our print publication or subscribe to our email alerts.
April 2018 Supplement